Glucagon-like peptide-1 receptor (GLP-1R) signaling ameliorates dysfunctional immunity in COPD patients

Glucagon-like peptide-1 receptor (GLP-1R) signaling ameliorates dysfunctional immunity in COPD patients

Jingwen Huang,1,* Huahua Yi,1,* Chunliu Zhao,2 Yifan Zhang,3 Liying Zhu,3 Bing Liu,1 Ping He,4 Min Zhou1 1Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2Department of Respiratory...

Full description

Bibliographic Details
Main Authors: Huang J, Yi H, Zhao C, Zhang Y, Zhu L, Liu B, He P, Zhou M
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:International Journal of COPD
Subjects:
Chronic obstructive pulmonary disease
Glucagon-like peptide-1 receptor
Liraglutide
interferon-
T-cell
Online Access:https://www.dovepress.com/glucagon-like-peptide-1-receptor-glp-1r-signaling-ameliorates-dysfunct-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/glucagon-like-peptide-1-receptor-glp-1r-signaling-ameliorates-dysfunct-peer-reviewed-article-COPD

Similar Items